Implications of Postprandial Hyperglycaemia and Role of Voglibose in Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus (T2DM) is a chronic disease which requires treatment to prevent further complications. The Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe (DECODE) study and diabetic intervention study demonstrated that high Postprandial Glucose (PPG) increase...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
2018-04-01
|
| Series: | Journal of Clinical and Diagnostic Research |
| Subjects: | |
| Online Access: | https://jcdr.net/articles/PDF/11399/32803_CE_F(AnG)_PF1(MJ_AP)_PFA(MJ_AP)_PB(MJ_AP)_PN(AP).pdf |
| _version_ | 1819039259410038784 |
|---|---|
| author | S R Pattanaik Parag Shah Abu Baker Navin Sinha Neeraj Kumar Onkar C Swami |
| author_facet | S R Pattanaik Parag Shah Abu Baker Navin Sinha Neeraj Kumar Onkar C Swami |
| author_sort | S R Pattanaik |
| collection | DOAJ |
| description | Type 2 Diabetes Mellitus (T2DM) is a chronic disease which requires treatment to prevent further complications. The Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe (DECODE) study and diabetic intervention study demonstrated that high Postprandial Glucose (PPG) increased the mortality and cardiovascular complications. Voglibose, an ɑ-glucosidase inhibitor, controls PPG level and have cardiovascular benefits. Objective of this article was to review postprandial hyperglycaemia and clinical evidences of voglibose in management of PPG in T2DM patients, its role in prediabetic condition and cardiovascular benefits. Extensive search work was conducted on Google, Google scholar and PubMed from January, 1990 to May, 2017. Studies relevant to pharmacology, efficacy and safety of voglibose were included in the article. Voglibose significantly reduces the PPG level in T2DM patients compared to other antidiabetic drugs. Superior control on PPG contributes to cardioprotective action. Beyond PPG regulation, voglibose has an effective role on prediabetic condition. Weak absorption of voglibose through intestine make it a drug of choice in elderly patients or in hepatic impairment and mild to moderate renal function impairments when other anti-diabetic agents are contraindicated. Clinical studies on voglibose, highlighted its role to control PPG level in T2DM patients and its cardiovascular benefits. |
| first_indexed | 2024-12-21T08:50:22Z |
| format | Article |
| id | doaj.art-0ba6b03c35d94443b5b6ccbe8d4515df |
| institution | Directory Open Access Journal |
| issn | 2249-782X 0973-709X |
| language | English |
| last_indexed | 2024-12-21T08:50:22Z |
| publishDate | 2018-04-01 |
| publisher | JCDR Research and Publications Private Limited |
| record_format | Article |
| series | Journal of Clinical and Diagnostic Research |
| spelling | doaj.art-0ba6b03c35d94443b5b6ccbe8d4515df2022-12-21T19:09:41ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2018-04-01124OE08OE1210.7860/JCDR/2018/32803.11399Implications of Postprandial Hyperglycaemia and Role of Voglibose in Type 2 Diabetes MellitusS R Pattanaik0Parag Shah1Abu Baker2Navin Sinha3Neeraj Kumar4Onkar C Swami5Consultant Diabetologist and Endocrinologist, Cuttack, Odisha, India.Consultant Diabetologist and Endocrinologist, Ahmedabad, Gujarat, India.Consultant Diabetologist, Hyderabad, Telangana, India.Consultant Diabetologist, Patna, Bihar, India.Assistant Manager, Medical Services, Torrent Pharmaceuticals Limited, Ahmedabad, Gujarat, India.General Manager, Medical Services, Torrent Pharmaceuticals Limited, Ahmedabad, Gujarat, India.Type 2 Diabetes Mellitus (T2DM) is a chronic disease which requires treatment to prevent further complications. The Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe (DECODE) study and diabetic intervention study demonstrated that high Postprandial Glucose (PPG) increased the mortality and cardiovascular complications. Voglibose, an ɑ-glucosidase inhibitor, controls PPG level and have cardiovascular benefits. Objective of this article was to review postprandial hyperglycaemia and clinical evidences of voglibose in management of PPG in T2DM patients, its role in prediabetic condition and cardiovascular benefits. Extensive search work was conducted on Google, Google scholar and PubMed from January, 1990 to May, 2017. Studies relevant to pharmacology, efficacy and safety of voglibose were included in the article. Voglibose significantly reduces the PPG level in T2DM patients compared to other antidiabetic drugs. Superior control on PPG contributes to cardioprotective action. Beyond PPG regulation, voglibose has an effective role on prediabetic condition. Weak absorption of voglibose through intestine make it a drug of choice in elderly patients or in hepatic impairment and mild to moderate renal function impairments when other anti-diabetic agents are contraindicated. Clinical studies on voglibose, highlighted its role to control PPG level in T2DM patients and its cardiovascular benefits.https://jcdr.net/articles/PDF/11399/32803_CE_F(AnG)_PF1(MJ_AP)_PFA(MJ_AP)_PB(MJ_AP)_PN(AP).pdfɑ-glucosidase inhibitorscardiovascularglucagon like peptide-1prediabetes |
| spellingShingle | S R Pattanaik Parag Shah Abu Baker Navin Sinha Neeraj Kumar Onkar C Swami Implications of Postprandial Hyperglycaemia and Role of Voglibose in Type 2 Diabetes Mellitus Journal of Clinical and Diagnostic Research ɑ-glucosidase inhibitors cardiovascular glucagon like peptide-1 prediabetes |
| title | Implications of Postprandial Hyperglycaemia and Role of Voglibose in Type 2 Diabetes Mellitus |
| title_full | Implications of Postprandial Hyperglycaemia and Role of Voglibose in Type 2 Diabetes Mellitus |
| title_fullStr | Implications of Postprandial Hyperglycaemia and Role of Voglibose in Type 2 Diabetes Mellitus |
| title_full_unstemmed | Implications of Postprandial Hyperglycaemia and Role of Voglibose in Type 2 Diabetes Mellitus |
| title_short | Implications of Postprandial Hyperglycaemia and Role of Voglibose in Type 2 Diabetes Mellitus |
| title_sort | implications of postprandial hyperglycaemia and role of voglibose in type 2 diabetes mellitus |
| topic | ɑ-glucosidase inhibitors cardiovascular glucagon like peptide-1 prediabetes |
| url | https://jcdr.net/articles/PDF/11399/32803_CE_F(AnG)_PF1(MJ_AP)_PFA(MJ_AP)_PB(MJ_AP)_PN(AP).pdf |
| work_keys_str_mv | AT srpattanaik implicationsofpostprandialhyperglycaemiaandroleofvogliboseintype2diabetesmellitus AT paragshah implicationsofpostprandialhyperglycaemiaandroleofvogliboseintype2diabetesmellitus AT abubaker implicationsofpostprandialhyperglycaemiaandroleofvogliboseintype2diabetesmellitus AT navinsinha implicationsofpostprandialhyperglycaemiaandroleofvogliboseintype2diabetesmellitus AT neerajkumar implicationsofpostprandialhyperglycaemiaandroleofvogliboseintype2diabetesmellitus AT onkarcswami implicationsofpostprandialhyperglycaemiaandroleofvogliboseintype2diabetesmellitus |